Copyright Reports & Markets. All rights reserved.

Global Alcohol Addiction Therapeutics Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Alcohol Addiction Therapeutics

      • 1.1 Definition of Alcohol Addiction Therapeutics
      • 1.2 Alcohol Addiction Therapeutics Segment by Type
        • 1.2.1 Global Alcohol Addiction Therapeutics Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 CM-1212
        • 1.2.3 CTDP-002
        • 1.2.4 A-705253
        • 1.2.5 ABT-436
        • 1.2.6 ADX-71441
        • 1.2.7 Others
      • 1.3 Alcohol Addiction Therapeutics Segment by Applications
        • 1.3.1 Global Alcohol Addiction Therapeutics Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Alcohol Addiction Therapeutics Overall Market
        • 1.4.1 Global Alcohol Addiction Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Alcohol Addiction Therapeutics Production (2014-2025)
        • 1.4.3 North America Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
        • 1.4.4 Europe Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
        • 1.4.5 China Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
        • 1.4.6 Japan Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Alcohol Addiction Therapeutics Status and Prospect (2014-2025)
        • 1.4.8 India Alcohol Addiction Therapeutics Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Alcohol Addiction Therapeutics
      • 2.3 Manufacturing Process Analysis of Alcohol Addiction Therapeutics
      • 2.4 Industry Chain Structure of Alcohol Addiction Therapeutics

      3 Development and Manufacturing Plants Analysis of Alcohol Addiction Therapeutics

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Alcohol Addiction Therapeutics Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Alcohol Addiction Therapeutics
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Alcohol Addiction Therapeutics Production and Capacity Analysis
      • 4.2 Alcohol Addiction Therapeutics Revenue Analysis
      • 4.3 Alcohol Addiction Therapeutics Price Analysis
      • 4.4 Market Concentration Degree

      5 Alcohol Addiction Therapeutics Regional Market Analysis

      • 5.1 Alcohol Addiction Therapeutics Production by Regions
        • 5.1.1 Global Alcohol Addiction Therapeutics Production by Regions
        • 5.1.2 Global Alcohol Addiction Therapeutics Revenue by Regions
      • 5.2 Alcohol Addiction Therapeutics Consumption by Regions
      • 5.3 North America Alcohol Addiction Therapeutics Market Analysis
        • 5.3.1 North America Alcohol Addiction Therapeutics Production
        • 5.3.2 North America Alcohol Addiction Therapeutics Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Alcohol Addiction Therapeutics Import and Export
      • 5.4 Europe Alcohol Addiction Therapeutics Market Analysis
        • 5.4.1 Europe Alcohol Addiction Therapeutics Production
        • 5.4.2 Europe Alcohol Addiction Therapeutics Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Alcohol Addiction Therapeutics Import and Export
      • 5.5 China Alcohol Addiction Therapeutics Market Analysis
        • 5.5.1 China Alcohol Addiction Therapeutics Production
        • 5.5.2 China Alcohol Addiction Therapeutics Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Alcohol Addiction Therapeutics Import and Export
      • 5.6 Japan Alcohol Addiction Therapeutics Market Analysis
        • 5.6.1 Japan Alcohol Addiction Therapeutics Production
        • 5.6.2 Japan Alcohol Addiction Therapeutics Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Alcohol Addiction Therapeutics Import and Export
      • 5.7 Southeast Asia Alcohol Addiction Therapeutics Market Analysis
        • 5.7.1 Southeast Asia Alcohol Addiction Therapeutics Production
        • 5.7.2 Southeast Asia Alcohol Addiction Therapeutics Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Alcohol Addiction Therapeutics Import and Export
      • 5.8 India Alcohol Addiction Therapeutics Market Analysis
        • 5.8.1 India Alcohol Addiction Therapeutics Production
        • 5.8.2 India Alcohol Addiction Therapeutics Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Alcohol Addiction Therapeutics Import and Export

      6 Alcohol Addiction Therapeutics Segment Market Analysis (by Type)

      • 6.1 Global Alcohol Addiction Therapeutics Production by Type
      • 6.2 Global Alcohol Addiction Therapeutics Revenue by Type
      • 6.3 Alcohol Addiction Therapeutics Price by Type

      7 Alcohol Addiction Therapeutics Segment Market Analysis (by Application)

      • 7.1 Global Alcohol Addiction Therapeutics Consumption by Application
      • 7.2 Global Alcohol Addiction Therapeutics Consumption Market Share by Application (2014-2019)

      8 Alcohol Addiction Therapeutics Major Manufacturers Analysis

      • 8.1 AstraZeneca Plc
        • 8.1.1 AstraZeneca Plc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.1.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 BioCorRx Inc
        • 8.2.1 BioCorRx Inc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.2.2 BioCorRx Inc Product Introduction, Application and Specification
        • 8.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Bionex Pharmaceuticals LLC
        • 8.3.1 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.3.2 Bionex Pharmaceuticals LLC Product Introduction, Application and Specification
        • 8.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Cerecor Inc
        • 8.4.1 Cerecor Inc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.4.2 Cerecor Inc Product Introduction, Application and Specification
        • 8.4.3 Cerecor Inc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Chronos Therapeutics Ltd
        • 8.5.1 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.5.2 Chronos Therapeutics Ltd Product Introduction, Application and Specification
        • 8.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Corcept Therapeutics Inc
        • 8.6.1 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.6.2 Corcept Therapeutics Inc Product Introduction, Application and Specification
        • 8.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Curemark LLC
        • 8.7.1 Curemark LLC Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.7.2 Curemark LLC Product Introduction, Application and Specification
        • 8.7.3 Curemark LLC Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Eli Lilly and Company
        • 8.8.1 Eli Lilly and Company Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.8.2 Eli Lilly and Company Product Introduction, Application and Specification
        • 8.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Ethypharm SA
        • 8.9.1 Ethypharm SA Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.9.2 Ethypharm SA Product Introduction, Application and Specification
        • 8.9.3 Ethypharm SA Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 H. Lundbeck A/S
        • 8.10.1 H. Lundbeck A/S Alcohol Addiction Therapeutics Production Sites and Area Served
        • 8.10.2 H. Lundbeck A/S Product Introduction, Application and Specification
        • 8.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Heptares Therapeutics Ltd
      • 8.12 Indivior Plc
      • 8.13 Kinnov Therapeutics SAS
      • 8.14 Kyorin Pharmaceutical Co Ltd
      • 8.15 Lohocla Research Corp
      • 8.16 Montisera Ltd
      • 8.17 Omeros Corp
      • 8.18 Opiant Pharmaceuticals Inc

      9 Development Trend of Analysis of Alcohol Addiction Therapeutics Market

      • 9.1 Global Alcohol Addiction Therapeutics Market Trend Analysis
        • 9.1.1 Global Alcohol Addiction Therapeutics Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Alcohol Addiction Therapeutics Regional Market Trend
        • 9.2.1 North America Alcohol Addiction Therapeutics Forecast 2019-2025
        • 9.2.2 Europe Alcohol Addiction Therapeutics Forecast 2019-2025
        • 9.2.3 China Alcohol Addiction Therapeutics Forecast 2019-2025
        • 9.2.4 Japan Alcohol Addiction Therapeutics Forecast 2019-2025
        • 9.2.5 Southeast Asia Alcohol Addiction Therapeutics Forecast 2019-2025
        • 9.2.6 India Alcohol Addiction Therapeutics Forecast 2019-2025
      • 9.3 Alcohol Addiction Therapeutics Market Trend (Product Type)
      • 9.4 Alcohol Addiction Therapeutics Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Alcohol Addiction Therapeutics Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Alcohol Addiction Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Alcohol Addiction Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alcohol Addiction Therapeutics market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Alcohol Addiction Therapeutics in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Alcohol Addiction Therapeutics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        AstraZeneca Plc
        BioCorRx Inc
        Bionex Pharmaceuticals LLC
        Cerecor Inc
        Chronos Therapeutics Ltd
        Corcept Therapeutics Inc
        Curemark LLC
        Eli Lilly and Company
        Ethypharm SA
        H. Lundbeck A/S
        Heptares Therapeutics Ltd
        Indivior Plc
        Kinnov Therapeutics SAS
        Kyorin Pharmaceutical Co Ltd
        Lohocla Research Corp
        Montisera Ltd
        Omeros Corp
        Opiant Pharmaceuticals Inc

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        CM-1212
        CTDP-002
        A-705253
        ABT-436
        ADX-71441
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now